NCT07217028 2026-02-27
Study Evaluating [18F]NOTA-ABY030 for Safety and Tolerability of Indeterminate Primary and/or Metastatic Disease in Head and Neck Squamous Cell Carcinoma
Vanderbilt-Ingram Cancer Center
Phase 1 Not yet recruiting
Clinical Trials
7 trialsNCT06450080 2024-06-10
ClimaBio
Centre Hospitalier Universitaire, Amiens
Phase NA Recruiting
NCT06215612 2024-01-22
ctDNA and MRI Parameters in Head and Neck Cancer
Medical University of Vienna
Phase NA Not yet recruiting
NCT01020097 2020-04-28
Fluorine F 18 EF5 Positron Emission Tomography in Assessing Hypoxia in Patients With Newly Diagnosed Stage I, Stage II, Stage III, or Stage IV Head or Neck Squamous Cell Cancer of the Oral Cavity, Oropharynx, and Larynx
Abramson Cancer Center at Penn Medicine
Phase NA Completed
NCT03611205 2019-08-07
Interim Digital PET/CT in Predicting Outcomes for Participants With Locally Advanced Oropharyngeal Cancer Undergoing Chemoradiation Therapy
Ohio State University Comprehensive Cancer Center
Phase NA Withdrawn
NCT00038038 2012-08-01
Assessment of Head and Neck Tumor Hypoxia Using 18F-Fluoromisonidazole
M.D. Anderson Cancer Center
Phase NA Withdrawn
NCT00313027 2012-07-09
Cervical Nodal Mets in Squamous Cell Carcinoma of H&N - MRI, FDG-PET, & Histopathologic Correlation
Stanford University
Phase NA Completed